Gemoscan Canada Inc.  

(Public, CVE:GES.H)   Watch this stock  
Find more results for CVE:GES
Jan 4 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range     -
52 week     -
Open     -
Vol / Avg. 0.00/0.00
Mkt cap 192,080.00
P/E     -
Div/yield     -
EPS -0.04
Shares 37.62M
Beta     -
Inst. own     -

Key stats and ratios

Q3 (Sep '15) 2015
Net profit margin -35.10% -82.26%
Operating margin -23.80% -55.70%
EBITD margin - -37.60%
Return on average assets -81.90% -151.32%
Return on average equity - -
Employees 13 -
CDP Score - -


601 Magnetic Dr Unit 39
+1-416-6501200 (Phone)
+1-416-9079147 (Fax)


Gemoscan Canada, Inc. is a Canada-based company, which is engaged in food intolerance management. The Company develops, owns and markets naturopathic dietary management solutions for consumers, including the Hemocode System and the MenuWise Plan, personalized medically supervised programs that promote dietary well-being. The Company operates through two segments: one engaged in marketing the HEMOCODE Food Intolerance System and other similar services related to the provision of consultation and recommendations to simplify the management of food sensitivities and the other involved in the management and operations of health and paramedical clinics. The HEMOCODE Food Intolerance System identifies specific food intolerances. The Company also owns and operates multidisciplinary paramedical clinics, located in Toronto, Ontario. The Company's three wholly owned subsidiaries include Physiomed Kennedy Inc. (PKI), 2383666 Ontario Inc. and Hemocode USA, Inc. (HUI).